Evolve Biosystems

Recent Finacing

Series D

Recent Raise

$55M

Evolve BioSystems develops activated B. infantis–based probiotic and prebiotic products (Evivo) and microbiome diagnostics to restore infant gut microbiota, supported by clinical trials from a UC Davis spin-out.

Founded 2011

California, United States

11-50

Private

evolvebiosystems.com

Highlights

Focus Areas

Biotechnology

Health Care

Medical

Medical Device

Recent Investors

S

Financials

$124M

Total Raised

4

Funding rounds

13

Investors

Team

Upgrade to view the team

See the team members at Evolve Biosystems.